Company: RGNT
Filing Date: 2025-05-19
Form Type: F-1/A
Source: 0001213900-25-045479
Chunk: 151

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-05-19
Form: F-1/A
Chunk 151
---
 claims or take legal actions to assert our rights, including
intellectual property rights as well as claims relating to employment matters and the safety or efficacy of our products. Any of these
claims could subject us to costly litigation and, while we generally believe that we have adequate insurance to cover many different types
of liabilities, our insurance carriers may deny coverage, may be inadequately capitalized to pay on valid claims, or our policy limits
may be inadequate to fully satisfy any damage awards or settlements. If this were to happen, the payment of any such awards could have
a material adverse effect on our operations, cash flows and financial position. Additionally, any such claims, whether or not successful,
could damage our reputation and business.

<div align='center'>88

MANAGEMENT</div>

Executive Officers and Directors

The following table sets forth
information regarding our executive officers and directors, including their ages as of the date of this prospectus:

| Name                    |     | Age |     | Position                |
| Dr. Ehud Geller         |     |  78 |     | Director, Chairman      |
| Mr. Jeff Dykan          |     |  65 |     | Director                |
| Mr. Keith Valentine     |     |  56 |     | Director(1)             |
| Dr. Eli Hazum           |     |  76 |     | Chief Executive Officer |
| Mr. Arie ‌ Gordashnikov |     |  41 |     | Chief Financial Officer |
| Efraim Cohen-Arazi      |     |  68 |     | Director Nominee(1)     |
| Mr. Pini Ben-Elazar     |     |  52 |     | Director Nominee(1)(2)  |
| Dr. Susan Alpert        |     |  76 |     | Director Nominee(1)(2)  |

| (1) | Indicates an Independent Director and a member of our Audit Committee and Compensation Committee. |

| (2) | Each of Mr. Ben-Elazar and Dr. Alpert will become a director at the effective time of the registration statement to which this prospectus relates, and will serve as an external director under the Companies Law subject to the ratification of his/her appointment at a general meeting of our shareholders to be held following the completion of this offering. |

Dr. Ehud Geller, Chairman of the Board of Directors

Dr.
Ehud Geller has served as the Chairman of